|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 10, 2015 ) The global influenza vaccine market is growing significantly due increasing awareness about the pandemic influenza viruses and increasing government involvement for vaccination against influenza viruses. Massive unexplored influenza vaccine markets in the emerging economies are creating ample opportunities for the global influenza vaccine market to grow at a significant rate in the forecasted period. The advanced research and development facilities and new vaccine developments by the companies are propelling the demand for safe and efficacious influenza vaccine. Influenza (flu) is a respiratory disease caused by mainly two types of influenza viruses namely, influenza A and B viruses. Influenza A viruses are of two types based on the proteins on the surface of virus: hemagglutinin (H) and neuraminidase (N).
View Full Report with TOC @ http://www.acutemarketreports.com/report/influenza-vaccine-market-size
In global influenza vaccine industry, there is a trend of development of intranasal vaccine due to the ease of self administration. According to Centers for Disease Control and Prevention (CDC),in 2009, approximately 151,700 to 575,400 people died due to H1N1 influenza pandemic or swine flu across the globe. In addition, the organization also reported that most deaths due to 2009 flu pandemic occurred in Africa and Southeast Asia region.
Several vaccines have been developed to prevent pandemic and seasonal influenza viruses using recombinant DNA technology and extensive researches are going on to develop efficient influenza vaccines using cell culture technology. Various governmental and non-governmental organizations have been actively involved in promoting and monitoring vaccination programs aimed at immunising people against seasonal influenza viruses. This in turn fuels the growth of global influenza vaccine market.
Influenza vaccine market can be categorized on the basis of vaccines, type of influenza viruses, and end-users. On the basis of vaccines, the influenza vaccine market can be categorized as Fluzone/Vaxigrip, Anflu, FluMist, Fluarix, FluLaval, Fluvax/Afluria, Fluvirin, and others. Based on type of influenza viruses, the influenza vaccine market can categorized as influenza A viruses, influenza B viruses, and others. On the basis of end-users, the influenza vaccine market can be segmented as pediatrics and adults.
Request a sample of Report @ http://www.acutemarketreports.com/request-free-sample/39816
Some of the factors driving the growth of the global influenza vaccine market are increasing research and development activities, increasing investment by companies for the development of influenza vaccine, technological advancements in recombinant DNA technology, large number of population with no immunization against influenza viruses in emerging economies, increasing healthcare expenditure, and increasing involvement of government and non-government organizations.
In addition, geriatric population and people suffering from chronic diseases are at higher risk of developing influenza virus infection; hence, aging population and increasing prevalence of chronic diseases are also driving the demand of influenza vaccine market. However, stringent regulatory framework and low accessibility to remote areas are some of the factors restraining the growth of the global influenza vaccine market to some extent.
Geographically, North America will be leading the global influenza vaccine market in the coming years, due to high awareness of influenza viruses, high healthcare expenditure, and increasing research and development activities. In addition, the U.S. Food and Drug Administration (FDA), recommends vaccination as the most effective method to prevent influenza; hence, fueling the growth of influenza vaccine market in NorthAmerica region. Asia-Pacificis the fastest growing region in the global influenza vaccine market. The major reasons for the fastest growth in the region are massive unexplored market (as large number of people donot have access to vaccination), increasing involvement of government, and increasing healthcare expenditure.
Some of the major players operating in the global influenza vaccine market are GlaxoSmithKline,Sanofi Pasteur, Inc., ID Biomedical Corporation, CSL Limited, Novartis, Protein Sciences Corporaton, MedImmune, LLC, Sinovac Biotech, Serum Institute of India, and Hualun Biologicalsamong others.
View all reports of this category @ http://www.acutemarketreports.com/category/healthcare-market
Report Coverage:
Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
Uncovers potential demands in the market
Porter analysis identifies competitive forces within the market
Provides information on the historical and current market size and the future potential of the market
About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Contact us:
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: www.acutemarketreports.com
Acute Market Reports
Chris Paul
+18554558662
sales@acutemarketreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
